Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Peer Support and Remote Monitoring for Type 2 Diabetes in Black Adults

Tests a peer support and remote monitoring program for Black adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Peer Support and Remote Patient Monitoring for Black Adults With Type 2 Diabetes

Key facts

Where
Birmingham, United StatesSee the site

Where in United States

  • Cooper Green Mercy Health SystemBirmingham, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Alabama at Birmingham
Trial code
NCT07181304
Record updated
30 October 2026
Original description
This study will include a type 1 hybrid effectiveness implementation study to evaluate the effectiveness of the PROMOTE (peer support plus remote patient monitoring) program among Black adults with uncontrolled type 2 diabetes recruited from local primary care practices in Jefferson County, Alabama. Additionally, a mixed methods evaluation to characterize the contextual factors relevant to implementation of PROMOTE using Practical Robust Implementation Science Model (PRISM) will be conducted.Read full original descriptionShow less

Peer Support and Remote Patient Monitoring for Black Adults With Type 2 Diabetes: PROMOTE Study

This study will include a type 1 hybrid effectiveness implementation study to evaluate the effectiveness of the PROMOTE (peer support plus remote patient monitoring) program among Black adults with uncontrolled type 2 diabetes recruited from local primary care practices in Jefferson County, Alabama. Additionally, a mixed methods evaluation to characterize the contextual factors relevant to implementation of PROMOTE using Practical Robust Implementation Science Model (PRISM) will be conducted.

Inclusion: Age 19 years or older; Black race (self-reported); Diagnosis of type 2 diabetes; Uncontrolled A1C >8%; Receipt of care at one of the study sites; Speaks and reads in English.

Exclusion: Limited English proficiency; Currently pregnancy; Non-community dwelling; Speaks and reads in English.

ClinicalTrials.gov NCT07181304